Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CAO Craig Gracey sold 2,083 shares of the business’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $19.01, for a total transaction of $39,597.83. Following the transaction, the chief accounting officer owned 5,025 shares in the company, valued at approximately $95,525.25. This trade represents a 29.31% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Craig Gracey also recently made the following trade(s):
- On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total transaction of $37,494.00.
- On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total value of $120,093.48.
Omada Health Stock Performance
Omada Health stock opened at $20.89 on Friday. The company has a market capitalization of $1.24 billion and a price-to-earnings ratio of -77.37. The stock has a fifty day moving average of $16.51 and a two-hundred day moving average of $14.85. Omada Health, Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $26.92.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the business. Bank of America Corp DE raised its stake in shares of Omada Health by 51.5% during the first quarter. Bank of America Corp DE now owns 161,099 shares of the company’s stock valued at $2,025,000 after purchasing an additional 54,792 shares in the last quarter. Stoic Point Capital Management LLC acquired a new position in shares of Omada Health during the 1st quarter valued at $1,830,000. Quantinno Capital Management LP grew its holdings in Omada Health by 464.1% during the first quarter. Quantinno Capital Management LP now owns 58,723 shares of the company’s stock worth $738,000 after acquiring an additional 48,313 shares during the period. Entropy Technologies LP bought a new stake in shares of Omada Health in the 1st quarter worth approximately $194,000. Finally, Renaissance Technologies LLC increased its holdings in shares of Omada Health by 173.9% in the first quarter. Renaissance Technologies LLC now owns 391,069 shares of the company’s stock valued at $4,916,000 after buying an additional 248,269 shares in the last quarter.
Wall Street Analyst Weigh In
A number of brokerages have commented on OMDA. Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a report on Friday, May 8th. Wall Street Zen raised shares of Omada Health from a “hold” rating to a “buy” rating in a report on Saturday. BMO Capital Markets dropped their price target on Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, March 6th. Evercore restated an “outperform” rating and set a $20.00 price objective on shares of Omada Health in a research note on Friday, May 8th. Finally, Needham & Company LLC reissued a “buy” rating and set a $28.00 price target on shares of Omada Health in a report on Friday, May 8th. Ten research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.
About Omada Health
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Read More
- Five stocks we like better than Omada Health
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
